|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 10-27 | Irlab Therapeutics Set to Obtain US Patent for Parkinson's Disease Drug Candidate | MT |
| 10-27 | Irlab receives positive patent notice in the US for IRL1117 | FW |
Stock exchange
Nasdaq Stockholm- kr
-
0
kr
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| IRLAB A | 2.080SEK | -0.48% | 1.34M kr | ||
Deutsche Boerse AG
| 6IRA | 0.1866EUR | -0.85% | 0 € | |
|
OTC Markets
| IRLAF | -USD | -.--% | 0 $ |
Basic data
Market Cap (SEK)
309,587,977
Market Cap (USD)
31,637,388
Net sales (SEK)
57,462,000
Net sales (USD)
5,872,152
Free-Float
83.4%
Free-Float capitalization (SEK)
147,473,770
Free-Float capitalization (USD)
15,070,627
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 31.64M | |
| -0.46% | +10.31% | +63.52% | +143.15% | 1,263B | |
| -0.97% | +1.60% | +43.25% | +80.09% | 658B | |
| -2.05% | +0.73% | +32.47% | +101.62% | 521B | |
| -1.54% | +0.18% | +53.42% | +66.79% | 391B | |
| -0.78% | +5.51% | +72.55% | +44.25% | 369B | |
| -1.69% | +3.17% | +32.49% | +55.35% | 307B | |
| -0.72% | +7.83% | +11.15% | +33.76% | 290B | |
| -0.12% | +4.68% | +55.97% | +74.59% | 252B | |
| -0.21% | +7.34% | +42.19% | +109.69% | 212B | |
| Average | -0.87% | +5.08% | +45.22% | +78.81% | 426.2B | |
| Weighted average by Cap. | -0.74% | +5.66% | +49.15% | +93.29% |
Historical Quotes: IRLAB Therapeutics AB
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- IRLAB A Stock
- Stock
- Quotes IRLAB Therapeutics AB
Select your edition
All financial news and data tailored to specific country editions
